The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease
Open accessPreprint — published as 10.1038/s41591-023-02543-w · Paper page
Abstract
Cellular senescence has been identified as a pathological mechanism linked to tau and amyloid beta (Aβ) accumulation in mouse models of Alzheimer's disease (AD). Clearance of senescent cells using the senolytic compounds dasatinib (D) and quercetin (Q) reduced neuropathological burden and improved clinically relevant outcomes in the mice. Herein, we conducted a vanguard open-label clinical trial of senolytic therapy for AD with the primary aim of evaluating central nervous system (CNS) penetrance, as well as exploratory data collection relevant to safety, feasibility, and efficacy. Participants with early-stage symptomatic AD were enrolled in an open-label, 12-week pilot study of intermittent orally-delivered D+Q. CNS penetrance was assessed by evaluating drug levels in cerebrospinal fluid (CSF) using high performance liquid chromatography with tandem mass spectrometry. Safety was continuously monitored with adverse event reporting, vitals, and laboratory work. Cognition, neuroimaging, and plasma and CSF biomarkers were assessed at baseline and post-treatment. Five participants (mean age: 76±5 years; 40% female) completed the trial. The treatment increased D and Q levels in the blood of all participants ranging from 12.7 to 73.5 ng/ml for D and 3.29-26.30 ng/ml for Q. D levels were detected in the CSF of four participants ranging from 0.281 to 0.536 ng/ml (t(4)=3.123, p=0.035); Q was not detected. Treatment was well-tolerated with no early discontinuation and six mild to moderate adverse events occurring across the study. Cognitive and neuroimaging endpoints did not significantly differ from baseline to post-treatment. CNS levels of IL-6 and GFAP increased from baseline to post-treatment (t(4)=3.913, p=008 and t(4)=3.354, p=0.028, respectively) concomitant with decreased levels of several cytokines and chemokines associated with senescence, and a trend toward higher levels of Aβ42 (t(4)=-2.338, p=0.079). Collectively the data indicate the CNS penetrance of D and provide preliminary support for the safety, tolerability, and feasibility of the intervention and suggest that astrocytes and Aβ may be particularly responsive to the treatment. While early results are promising, fully powered, placebo-controlled studies are needed to evaluate the potential of AD modification with the novel approach of targeting cellular senescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Dietary Intake and Bioavailability of Polyphenols
Scalbert, A., & Williamson, G. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.8.2073s · Cited by 3,658
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Self-citationA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
(2015) · HAL · Cited by 2,238
Health effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Morris, J. C. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004870 · Cited by 1,641
Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597
Cited by
Sorted by citations
Items 101–200 of 335
Mechanisms of cellular senescence-induced vascular aging: evidence of senotherapeutic strategies
Mahoney, S. A., Bloom, S. I., Seals, D. R., Donato, A. J., Rossman, M. J., & Clayton, Z. S. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.31 · Cited by 15
Kirchner, V. A., Badshah, J. S., Hong, S. K., Martinez, O. M., Pruett, T. L., & Niedernhofer, L. J. (2023) · Transplantation · doi:10.1097/tp.0000000000004838 · Cited by 15
Millar, C. L., Iloputaife, I., Baldyga, K., Kuo, J., Tchkonia, T., Kirkland, J. L., Travison, T. G., & Lipsitz, L. A. (2023) · Translational Medicine of Aging · doi:10.1016/j.tma.2023.10.004 · Cited by 14
Self-citationPhytochemical Nanoparticles for the Treatment of Neurological Disorders
Ehtezazi, T., & Sarker, S. D. (2025) · Phytochemical Analysis · doi:10.1002/pca.70020 · Cited by 13
Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Hroudová, J., & Fišar, Z. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111069 · Cited by 13
From bench to bedside: The critical need for standardized senescence detection
Shah, J., Al-Hashimi, A., Benedetto, M., & Ruchaya, P. J. (2025) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.12.008 · Cited by 13
Reinforcing Nrf2 Signaling: Help in the Alzheimer’s Disease Context
la Torre, A., Vecchio, F. L., Angelillis, V. S., Gravina, C., D’Onofrio, G., & Greco, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031130 · Cited by 13
Mielke, M. M., Fielding, R. A., Atkinson, E. J., Aversa, Z., Schafer, M. J., Cummings, S. R., Pahor, M., Leeuwenburgh, C., & LeBrasseur, N. K. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100529 · Cited by 13
Tosoni, G., Ayyildiz, D., Snoeck, S., Moreno‐Jiménez, E. P., Penning, A., Santiago-Mujika, E., Ormaechea, O. R., Lee, H., Poovathingal, S. K., Davie, K., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.04.002 · Cited by 13
Lemaı̂tre, J.-M. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19820 · Cited by 13
Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
Dey, A. K., Banarjee, R., Boroumand, M., Rutherford, D. V., Strassheim, Q., Nyunt, T., Olinger, B., & Basisty, N. (2023) · Biology · doi:10.3390/biology12101301 · Cited by 12
Dashtmian, A. R., Darvishi, F. B., & Arnold, W. D. (2024) · Cells · doi:10.3390/cells13110928 · Cited by 12
Arendash, G. W., Lin, X., & Cao, C. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240600 · Cited by 12
Chen, Y., Huang, H., Luo, Y., Wu, H., Deng, W., Min, X., Lao, H., & Xiong, H. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156772 · Cited by 12
Yang, B., Yang, K., Xi, R., Li, S., Chen, J., & Wu, Y. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103716 · Cited by 12
Exercise to Mitigate Cerebrovascular Aging: A Geroscience Perspective
Norling, A. M., & Lipsitz, L. A. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae083 · Cited by 12
Senescence- and Immunity-Related Changes in the Central Nervous System: A Comprehensive Review
Feng, H., Li, J., Wang, H., Wei, Z., & Feng, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0755 · Cited by 11
Ma, M., Zeng, J., Zhu, M., Li, H., Lin, T., Yang, H., Wei, X. C., & Song, T. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002074 · Cited by 11
Gao, X., Hu, Y., Zhang, Y., Huang, Y., Zhang, G., Zhang, X., Zhou, Y., & Zhang, D. (2025) · Science Advances · doi:10.1126/sciadv.adr2833 · Cited by 11
Lambert, M., Miquel, G., Villeneuve, L. R., Thorin‐Trescases, N., & Thorin, É. (2025) · GeroScience · doi:10.1007/s11357-025-01563-3 · Cited by 11
An "inside-out"-guided genetically engineered hydrogel for augmenting aged bone regeneration
Zhu, Y., Sun, L., Hou, M., Yu, J., Yu, C., Zhang, Z., Yang, H., Liu, C., Huang, L., Jiang, D., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.05.003 · Cited by 11
Suk, K. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115737 · Cited by 11
Tchkonia, T., Kritchevsky, S. B., Kuchel, G. A., & Kirkland, J. L. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18901 · Cited by 11
Self-citationSystematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li, W., Xie, Y., Jia-Xin, M., Shu-Chao, G., & Li-Ping, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149480 · Cited by 11
Sangfuang, N., McCoubrey, L. E., Awad, A., Marzorati, M., Ghyselinck, J., Verstrepen, L., Munck, J. D., Medts, J. D., Gaisford, S., & Basit, A. W. (2025) · Translational research · doi:10.1016/j.trsl.2025.02.004 · Cited by 10
A human neuron Alzheimer’s disease model reveals barriers to senolytic translatability
Walton, C. C., Wang, E. Y., Lee, S., Siebrand, C. J., Bergo, N. J., Mayeri, Z., & Andersen, J. K. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01822-7 · Cited by 10
Liu, W., Fan, B., Fang, T., Li, H., Zhang, J., Liu, B., & Liu, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.010 · Cited by 10
Towards a personalized approach in senolytic trials
Khosla, S., Monroe, D. G., & Farr, J. N. (2025) · Nature Aging · doi:10.1038/s43587-025-00964-5 · Cited by 10
Fan, Y. Z., Lian, X., Ren, X., Ren, L., Liu, C., Meng, Y., & Zhang, L. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1690170 · Cited by 10
Singh, I., & Singh, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05504-1 · Cited by 10
Kourti, M., & Kontoghiorghes, G. J. (2025) · Antioxidants · doi:10.3390/antiox15010015 · Cited by 11
Bertoni, G., Ristori, S., & Monti, D. (2026) · Cells · doi:10.3390/cells15080657 · Cited by 10
Insights into the therapeutic strategies for aging and aging-associated diseases
Dong, R., Wu, Q., Kan, J., Fu, C., Sorrentino, V., Chow, A., Lei, Y., Wu, D., Xu, Z., Du, J., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02662-z · Cited by 12
Chen, X., Walton, K. L., Brodaty, H., & Chalton, K. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231222 · Cited by 10
Dementia research in 2023: the year of anti-amyloid immunotherapy
Delrieu, J., Andrieu, S., & Vellas, B. J. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00449-0 · Cited by 10
Yang, Y., Cai, Q., Zhu, M., Rong, J., Feng, X., & Wang, K. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123678 · Cited by 9
Frost, B. E., Rowe, J. B., Akinyemi, R., Abisambra, J. F., Ashton, N. J., Brendel, M., Buée, L., Butler, D., Carrillo, M. C., Chung, P. S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70078 · Cited by 9
Self-citationCellular senescence as a therapeutic target for aging intervention
Bi, Y., & Ji, G. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.100948 · Cited by 9
Cheminant, J. R., Deering‐Rice, C. E., Massa, C. B., Adhikari, U., Noll, J., Reilly, C. A., & Venosa, A. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00261.2024 · Cited by 9
Non-oncogene dependencies: Novel opportunities for cancer therapy
Marco, T. D., Mazzoni, M., Greco, A., & Cassinelli, G. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116254 · Cited by 9
Exploring senescence as a modifier of β cell extracellular vesicles in type 1 diabetes
Motlagh, R. A., Pipella, J., & Thompson, P. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1422279 · Cited by 8
Flores-Torres, R. P., Salas-Venegas, V., Santín-Márquez, R., la Vega-Tinajar, M. D., Carreto, R. J. R., Librado‐Osorio, R., Luna‐López, A., Alarcón‐Aguilar, A., López‐Díazguerrero, N. E., Morán‐Ramos, S., et al. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115331 · Cited by 8
Zhu, Y., Luo, D., Shen, X., Shi, Q., Lv, H., Zhang, S., Ye, F., & Kong, N. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03114-4 · Cited by 8
Drug repurposing for Alzheimer’s disease: a Delphi consensus and stakeholder consultation
Corbett, A., Sultana, J., Stych, K., Mills, R., Cummings, J., Williams, G., Ismail, Z., Soto‐Martin, M., Mintzer, J. E., Gauthier, S. G., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01895-4 · Cited by 8
Antioxidant Senotherapy by Natural Compounds: A Beneficial Partner in Cancer Treatment
Aleksandrova, Y. R., & Неганова, М. Е. (2025) · Antioxidants · doi:10.3390/antiox14020199 · Cited by 8
Bianchini, M. C., Franscescon, F., Soares, A. A., Ansolin, V., Pretto, K. P., da Cunha, M. L. V., & Silva, D. T. D. R. E. (2025) · Current Neuropharmacology · doi:10.2174/011570159x355614250130100132 · Cited by 8
Senolytic therapy for Alzheimer’s disease
Longo, F. M., & Massa, S. M. (2023) · Nature Medicine · doi:10.1038/s41591-023-02541-y · Cited by 8
Orr, M. E., Garbarino, V. R., Palavicini, J., Melendez, J., Barthélemy, N. R., He, Y., Kautz, T. F., Lopez‐Cruzan, M., Mathews, J. J., Xu, P., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3994894/v1 · Cited by 8
Self-citationGuo, Y., Cao, H., Zuo, C., Huang, Y., Gu, Z., Song, Y., Chen, X., Jiang, Q., & Wang, F. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02072-7 · Cited by 7
Evaluating senescence-targeted approaches in Alzheimer’s Disease: What we know and what lies ahead
Doshi, P. P., Desale, S. H., Khutale, A. A., Sabarathinam, S., & Suresh, S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103029 · Cited by 7
Piva, M., Martelossi-Cebinelli, G., Mendes-Pierotti, S., Chinen, W. H., Cardines, P. H. F., Martinez, R. M., Georgetti, S. R., Baracat, M. M., Vicentini, F. T. M. C., Verri, W. A., Jr., et al. (2026) · Foods · doi:10.3390/foods15122159 · Cited by 7
Rovira, I. I., Biragyn, A., Brown, L. L., Galis, Z. S., Klauzińska, M., Kotliarova, S. E., Simmons, J. M., Wali, A., Xi, D., Yarden, R. I., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1462217 · Cited by 7
Horikawa, I., Yamada, L., Harris, B. T., & Harris, C. C. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.06.031 · Cited by 7
Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach
Atkinson, J., Dokiburra, A., Groover, H., Godbout, J. P., Segal, B. M., & Zhang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1681724 · Cited by 6
The drug discovery and therapeutic nano-strategies targeting cellular senescence
Wang, Y., Liu, M., Chen, X., Wang, S., Li, J., Sun, Y., Zheng, X., Zhang, J.-X., & Li, H. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102480 · Cited by 6
Senotherapeutics for metabolic disease and diabetic complications
Palmer, A. K., Spinelli, R., Prata, L. G. P. L., Chaib, S., Suda, M., Tchkonia, T., Smith, U., & Kirkland, J. L. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70039 · Cited by 6
Self-citationPréfontaine, C., Pipella, J., Heidinger, I., Alcasid, N., & Thompson, P. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-24506-6 · Cited by 6
Xu, Q., Li, G., Zhang, H., Jiang, Z., Gao, X., Li, Z., Prata, L. G. P. L., Kirkland, J. L., Zhang, G., & Sun, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-70302-9 · Cited by 6
Self-citationTranscranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity?
Arendash, G. W., & Cao, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119652 · Cited by 6
Iga, J., Yoshino, Y., Ozaki, T., Tachibana, A., Kumon, H., Funahashi, Y., Mori, H., Ueno, M., Ozaki, Y., Yamazaki, K., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241307878 · Cited by 6
Nano-encapsulated senolytic cocktail attenuates germ cell senescence in female mice
Guan, Y., Deng, S., Zou, X., Wei, W., Li, Z., Zhong, J., Zhu, Y., Zhang, D., Ju, Y., Sun, Q., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05697-7 · Cited by 6
Wong, L. P., Alias, H., Tan, K. M., Wong, P., Murugan, D. D., Hu, Z., & Lin, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1254470 · Cited by 6
Zare, M.-S., Abedpoor, N., Hajibabaie, F., & Walker, A. K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106944 · Cited by 6
A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain
Orr, M. E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231462 · Cited by 6
Self-citationPharmacological frontiers in senescence: Transforming senescence with drug repurposing
Shahzadi, A., Özyazgan, S., & Çakatay, U. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.02.010 · Cited by 5
Aliashrafzadeh, H., Liu, D., Alba, S. D., Akbar, I., Lui, A., Vanleuven, J., Martin, R. M., Wang, Z., & Liu, D. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.1008116 · Cited by 5
Shingles vaccination and neuroimmune vulnerability
Huang, X., & Gu, B. J. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.07.003 · Cited by 5
From Genome to Geroscience: How DNA Damage Shapes Systemic Decline
Siametis, A., & Garinis, G. A. (2025) · BioEssays · doi:10.1002/bies.70051 · Cited by 5
Liu, J., Zhang, Z., Yu, G., & Han, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70583 · Cited by 5
Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics
Garzon-Escamilla, N., Medina-Cardena, M., Roy, P., Trent, J., Jamous, J., Somesan, Y., & Denslow, S. (2026) · Biomedicines · doi:10.3390/biomedicines14020316 · Cited by 5
Shanker, P. R., & Dorajoo, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031613 · Cited by 5
Sweeney, E. M., Abate, G., Bakker, B. R. V., Mastinu, A., Lai, Y., Uberti, D. L., Nilsson, P., & Tambaro, S. (2026) · Aging Cell · doi:10.1111/acel.70478 · Cited by 5
The Aging Immune System: A Critical Attack on Ischemic Stroke
Xu, W., Guo, Y., Zhao, L., Fu, R., Qin, X., Zhang, Y., Cheng, X., & Xu, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04464-2 · Cited by 5
Lam, T. D., Tóth, I., Hermenean, A. O., Wilhelm, I., Kiéda, C., Krizbai, I. A., & Farkas, A. E. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04042-2 · Cited by 5
The potential for senotherapy as a novel approach to extend life quality in veterinary medicine
Williams, Z. J., Chow, L., Dow, S., & Pezzanite, L. M. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1369153 · Cited by 5
Role of astrocytes in Alzheimer's disease pathogenesis and the impact of exercise-induced remodeling
Shao, J., Deng, Q., Feng, S., Wu, C., Liu, X., & Yang, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150418 · Cited by 5
The Neuroprotective Potential of Polyphenols in Neurodegenerative Diseases
Wojciechowska, O. (2024) · Food Science and Nutrition Cases · doi:10.1079/fsncases.2024.0005 · Cited by 4
Guan, Y., Bai, X., Li, C., Zhang, Z., He, Q., Chen, L., Xie, Y., & Wang, Z. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101871 · Cited by 4
Mechanisms of aging in the cardiovascular system: challenges and opportunities
Zhao, X., Yang, X., Lin, Y., Lei, R., Ding, W., He, X.-Y., Cao, Y. J., Zhang, D., Liu, P., Liang, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1635736 · Cited by 4
Yuan, X., Gao, L., Peng, Y., She, T., & Wang, J. (2025) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2025.103301 · Cited by 4
Xie, Z., Chen, Z., Wu, W., Fei, M., Li, W., Cao, S., Wang, N., Sun, X., Sun, X., Liu, Q., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123863 · Cited by 4
Decoding senescent drivers in Alzheimer's disease: From bench to bedside
Zhou, R., Lin, X., Liao, Z., Lin, J., Zheng, R., Ni, H., Liu, W., Feng, Z., He, Q., Lin, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102978 · Cited by 4
Luo, Y., Yang, F., He, Y., Lin, J., & Chen, W. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70166 · Cited by 4
Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
Yan, R., Feng, H., & Zhang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1749278 · Cited by 4
Yang, Q., Xie, C., Luo, Z., Huang, W., Zhang, Z., Ren, K., Xu, X., HE, H., He, M., & Yin, L. (2026) · Redox Report · doi:10.1080/13510002.2026.2632434 · Cited by 4
Cellular Senescence in Neurodegeneration: From Cell Types to Therapeutic Opportunities
Zawadzka, M., Rydzek, J., Lizon, J., Krupa, Z., Wrona, J., & Woźniak, S. (2026) · Biomedicines · doi:10.3390/biomedicines14040758 · Cited by 4
Ma, J., Yang, B., Jiang, X., Wang, L., Wei, W., Cao, Y., & Li, H. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113177 · Cited by 4
Hou, J., Chen, K.-X., Xiao, Q.-N., Hu, C., Wei, J., Jiang, Y.-Z., Liu, L., He, C., Huang, M., Jiao, Y., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01130-1 · Cited by 4
Bramwell, L. R., Frankum, R., & Harries, L. W. (2024) · Cells · doi:10.3390/cells13060517 · Cited by 4
Huang, Y., Zhou, Y., He, Z., Yang, J., Gu, J., Cui, B., Li, S., Deng, H., Zhao, W., Yang, X., et al. (2025) · Inflammation · doi:10.1007/s10753-024-02213-0 · Cited by 4
Garay, R. P. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00040 · Cited by 4
Inflammatory β-Cell Stress and Immune Surveillance in Type 1 DiabetesPreprint
Bhushan, A., & Thompson, P. J. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041605 · Cited by 4
Plasma senescence associated secretory proteins: A new link to mild cognitive impairment
Banarjee, R., & Basisty, N. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100561 · Cited by 4
Castro, C., Delwarde, C., Shi, Y., & Roh, J. D. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.15 · Cited by 3
Ng, B., Kodosaki, E., Veleva, E., Keshavan, A., Schott, J. M., Heslegrave, A., Fox, N. C., & Zetterberg, H. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71082 · Cited by 3
Identification of miR-106b-5p as a senolytic miRNA
Zhang, T., Nunes, A., O'Kelly, R. D., Angelini, L. A., Masternak, M. M., Suh, Y., Dong, X., Niedernhofer, L. J., & Robbins, P. D. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105810 · Cited by 3
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
Nakamichi, S., Yamada, L., Roselle, C., Horikawa, I., June, C. H., & Harris, C. C. (2025) · GeroScience · doi:10.1007/s11357-025-01819-y · Cited by 3
Ding, M.-R., Xia, C.-Y., Qu, Y.-J., Zhang, L.-M., Zhang, M., Zhen, R.-R., Zhang, T., Chen, J.-F., Hu, B., & An, H.-M. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500806 · Cited by 3
Metadata
- Authors
- Orr, M., Gonzales, M., Garbarino, V., Kautz, T., Palavicini, J., Lopez-Cruzan, M., Dehkordi, S. K., Mathews, J., Zare, H., Xu, P., Zhang, B., Franklin, C., Habes, M., Craft, S., Petersen, R., Tchkonia, T., Kirkland, J., Salardini, A., Seshadri, S., & Musi, N.
- Affiliations
- W. G. (Bill) Hefner VA Medical Center (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Texas Health Science Center
- Icahn School of Medicine at Mount Sinai (US)
- Wake Forest University Health Sciences (US)
- Mayo Clinic (US)
- Mayo Clinic
- Boston University (US)
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Orr, Miranda
- Gonzales, Mitzi
- ORCID
- Venue
- Nature Medicine
- Published
- 2023-04-24
- Volume
- 29
- Issue
- 10
- Pages
- 2481-2488
- ISSN
- 1078-8956 (ISSN-L)
- PMC
- PMC10875739
- OpenAlex
- W4386499275
- Cited by
- 319
- References
- 64
- Citations by year
- 2026: 100 · 2025: 116 · 2024: 82 · 2023: 21
- FWCI
- 56.36
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Nature Medicine (publishedVersion)
- Research Square (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- PubMed Central (submittedVersion, cc-by)
- ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley) (submittedVersion)
- Funders
- Hevolution Foundation
- U.S. Department of Health and Human Services (TR002647, RF1AG059421, T32-AG021890, P30 AG062677, R01AG068293, R37AG13925, U01AG22307, R01AG080821, UF1 NS125417, R21NS125171, U19AG024904, R01AG069690, P30 AG066546, U54AG07594, R33AG061456, U01 AG046170, 1R01AG065301, R01AG054076, R01NS017950, P01AG062413, P30-AG013319, R01AG077472, R01AG068030, R01AG075684, R01AG033193, U01 AG006786, U24AG059624, PG30AG044271, U19NS115388, P30AG044271, R01AG066524, 1R01AG0665241A, P30AG072947, R01AG057896, U24 AG057437, 1RF1AG063507, RF1NS112391)
- U.S. Department of Veterans Affairs (I01 BX005717, P30AG013319)
- Alzheimer's Association (PTC REG-20-651687)
- American Federation for Aging Research
- Alzheimer's Drug Discovery Foundation (AG059421, GC-201908-2019443)
- Cure Alzheimer's Fund
- McGill University
- GHR Foundation
- Noaber Foundation
- National Heart and Lung Institute (R01HL105756)
- National Institutes of Health (4r01ag065301-03, TL1TR002647)
- University of Texas Health Science Center at San Antonio (TR002647)
- National Institute on Aging (R24AG073199, 1R01AG0665241A, RF1AG065301, U01AG22307, AG054076, U01AG046170, R01AG066524, R01AG069690, U01AG006786, R37 AG13925, R01AG068030, U54AG07594, R01AG057896, R01AG054076, R01AG065839, R01AG013925, 1R01AG065301, R01 AG065301, AG059421, PG30AG044271, RF1AG063507, R01AG033193, T32AG021890, RF1AG059421, R33AG061456, P30AG013319, U01AG022307, R37AG013925, R01AG080821, R01AG077472, U24AG057437, U19AG024904, U24AG059624, U54AG079754, P01AG062413, P30AG062677, R01AG068293, P30AG044271, P30AG072947, R01AG075684, P30AG066546)
- National Heart, Lung, and Blood Institute (R01HL105756)
- National Institute of Neurological Disorders and Stroke (R21NS125171, U19NS115388, RF1NS112391, UF1NS125417, R01NS017950)
- National Center for Advancing Translational Sciences (TR002647)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- senolytic therapy, Alzheimer's disease, cellular senescence, dasatinib, quercetin, oral drug delivery, CNS penetration, cerebrospinal fluid drug concentration, drug safety and tolerability, interleukin-6, glial fibrillary acidic protein, amyloid-beta 42, aging biomarkers, early Alzheimer's disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
